Impact of COVID-19 on Innovation at Johnson & Johnson with Alex Gorsky

Alex Gorsky, Chairman and CEO of Johnson & Johnson, joined Dr. Toby Cosgrove, Senior Partner, and Tim Berkowitz, Co-Founder, President and CEO, both of InnovaHealth Partners, for a conversation about the impact of COVID-19 on innovation and what it means for Johnson & Johnson in particular.

Key topics:

• Johnson & Johnson’s progress in developing a vaccine;
• How COVID-19 has impacted innovation in the healthcare industry, especially in the medtech and pharma sectors;
• The future of innovation in Johnson & Johnson’s own medtech and pharma businesses given the COVID-19 crisis;
• The vision behind the expansion of Johnson & Johnson’s robotics platforms.

Fill out the form to watch the video